Literature DB >> 25240053

CKIP-1 suppresses the adipogenesis of mesenchymal stem cells by enhancing HDAC1-associated repression of C/EBPα.

Dahu Li1, Heng Zhu2, Chao Liang3, Wenbo Li3, Guichun Xing3, Lanzhi Ma4, Lujing Ding4, Yi Zhang5, Fuchu He6, Lingqiang Zhang7.   

Abstract

Mesenchymal stem cells (MSCs) are considered as the developmental origin of multiple lineage cells including osteocytes, adipocytes, and muscle cells. Previous studies demonstrated that the PH domain-containing protein CKIP-1 plays an important role in the development of osteoblasts and cardiomyocytes. However, whether CKIP-1 is involved in the generation of adipocytes as well as the MSC differentiation remains unknown. Here we show that CKIP-1 is a novel regulator of MSCs differentiating into adipocytes. MSCs derived from CKIP-1-deficient mice display enhanced adipogenesis upon induction. Further analysis showed that CKIP-1 interacts with the histone deacetylase HDAC1 in the nucleus and inhibits the transcription of CCAAT/enhancer-binding protein α (C/EBPα), which is a crucial adipogenic transcription factor. Ectopic expression of CKIP-1 in a MSC-like cell line C3H/10T1/2 reduced the generation of adipocytes due to suppression of adipogenic factors, including C/EBPα. Moreover, CKIP-1-deficient mice showed an increase in body weight and white adipose tissue gains when fed on a high-fat diet. Collectively, these results suggest that CKIP-1 is a novel inhibitor of MSC-originated adipogenesis by enhancing HDAC1-associated repression of C/EBPα.
© The Author (2014). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.

Entities:  

Keywords:  C/EBPα, CKIP-1; HDAC1; adipogenesis; mesenchymal stem cells

Mesh:

Substances:

Year:  2014        PMID: 25240053     DOI: 10.1093/jmcb/mju034

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  7 in total

Review 1.  Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues.

Authors:  Huijuan Liu; Xuechun Xia; Baojie Li
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-18

2.  Psoralen alleviates radiation-induced bone injury by rescuing skeletal stem cell stemness through AKT-mediated upregulation of GSK-3β and NRF2.

Authors:  Bo-Feng Yin; Zhi-Ling Li; Zi-Qiao Yan; Zheng Guo; Jia-Wu Liang; Qian Wang; Zhi-Dong Zhao; Pei-Lin Li; Rui-Cong Hao; Meng-Yue Han; Xiao-Tong Li; Ning Mao; Li Ding; Da-Fu Chen; Yue Gao; Heng Zhu
Journal:  Stem Cell Res Ther       Date:  2022-06-07       Impact factor: 8.079

3.  POU2AF1 promotes MSCs adipogenesis by inhibiting HDAC1 expression.

Authors:  Yaqing Wang; Luyang Wang; Zhongping Su; Wei Sun; Mi Zhang; Chuanxi Yang; Jingxin Zhou; Li Jiang; Xiangqing Kong
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

4.  Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population.

Authors:  Mu-Peng Li; Yan-Jiao Zhang; Xiao-Lei Hu; Ji-Peng Zhou; Yong-Long Yang; Li-Ming Peng; Hong Qi; Tian-Lun Yang; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2017-05-30

5.  Increased PLEKHO1 within osteoblasts suppresses Smad-dependent BMP signaling to inhibit bone formation during aging.

Authors:  Jin Liu; Chao Liang; Baosheng Guo; Xiaohao Wu; Defang Li; Zongkang Zhang; Kang Zheng; Lei Dang; Xiaojuan He; Changwei Lu; Songlin Peng; Xiaohua Pan; Bao-Ting Zhang; Aiping Lu; Ge Zhang
Journal:  Aging Cell       Date:  2017-01-13       Impact factor: 9.304

6.  Ckip-1 regulates C3H10T1/2 mesenchymal cell proliferation and osteogenic differentiation via Lrp5.

Authors:  Xin Huang; Jianfei Liang; Ye Gao; Yan Hou; Yu Song; Liang Kong
Journal:  Exp Ther Med       Date:  2021-02-10       Impact factor: 2.447

7.  Cotransplantation of mesenchymal stem cells and endothelial progenitor cells for treating steroid-induced osteonecrosis of the femoral head.

Authors:  Haixia Xu; Chengqiang Wang; Chun Liu; Ziyue Peng; Jianjun Li; Yanglei Jin; Yihan Wang; Jiasong Guo; Lixin Zhu
Journal:  Stem Cells Transl Med       Date:  2021-01-13       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.